HYPERION DEFI, INC. Deferred Costs, Noncurrent
HYPERION DEFI, INC. (HYPD) had Deferred Costs, Noncurrent of $170.63 thousand as of 2024-06-30, per its 10-Q filed 2024-08-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredCosts · last filed 2024-08-14
- 2024-06-30: Deferred Costs, Noncurrent $170.63K.
- 2019-06-30: Deferred Costs, Noncurrent $77.38K.
- 2018-12-31: Deferred Costs, Noncurrent $0.00.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2024-06-30 | $170.63K 10-Q · filed 2024-08-14 |
| 2019-06-30 | $77.38K 10-Q · filed 2019-08-13 |
| 2018-12-31 | $0.00 10-Q · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |